Proactive Investors - Run By Investors For Investors

Rhinomed sits atop Friday’s most traded

Rhinomed sits atop Friday’s most traded

Friday’s leading volume stocks on the ASX.

Rhinomed ASX:RNO $0.052 92.6% 201,094,982
Collaborate Corp ASX:CL8 $0.038 -5% 27,035,631
Resmed Inc ASX:RMD $6.99 3.9% 26,895,241
Lynas Corporation ASX:LYC $0.044 -8.3% 22,371,166
Telstra Corporation ASX:TLS $6.20 0.8% 19,926,793
Eden Energy ASX:EDE $0.014 16.7% 19,924,909
Metcash Limited ASX:MTS $1.44 12.1% 18,719,733
Activistic Limited ASX:ACU $0.18 0% 17,162,582
Environmental Clean Technologies ASX:ESI $0.015 0% 16,759,616
FAR Limited ASX:FAR $0.088 -6.4% 16,006,613


Proactive Investors Australia is the market leader in producing news, articles and research reports on ASX emerging companies with distribution in Australia, UK, North America and Hong Kong / China.

View full RNO profile View Profile

Rhinomed Ltd Timeline

September 15 2015

Related Articles

human kidneys
May 06 2019
The Danish company is seeking FDA approval of the test for use in both adults and children
A man's knee pain is highlighted with a red area that points to inflammation
January 22 2019
The injectable PPS trial has had a clinically meaningful and statistically significant result in patients with arthritic knee pain.
June 21 2019
Belgium-based company’s Nu.Q test screens for colorectal and prostate cancers, and may have the potential to detect ovarian disease endometriosis
Copyright ©, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use